Acid Tolerance and Fecal Recovery Following Oral Administration of<i>Saccharomyces cerevisiae</i>
D. Scevola(Policlinico San Matteo Fondazione), P. Marone(Istituto Superiore di Sanità), C. Candiani(Novartis (Switzerland)), Bianca Castiglioni(Institute of Agricultural Biology and Biotechnology), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), L. Perversi(Policlinico San Matteo Fondazione), C. Cavanna(Policlinico San Matteo Fondazione)
Cited by 4
Related Papers
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
|New England Journal of Medicine|2001|168
Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy
|Annals of Internal Medicine|2002|136
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133
Real-Time PCR Assay for Clinical Management of Human Immunodeficiency Virus-Infected Patients with Visceral Leishmaniasis
|Journal of Clinical Microbiology|2003|122